Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydroxypropylcellulose + dextran is a combination of two polymer-based agents used primarily as ophthalmic lubricants and protectants. Hydroxypropylcellulose is a cellulose derivative that stabilizes and thickens the precorneal tear film, prolonging tear film breakup time and providing lubrication to relieve dryness and irritation in the eye[7]. Dextran, a polysaccharide, acts as an ocular lubricant by mimicking natural tears to temporarily relieve symptoms of dry eyes such as burning, itching, or foreign body sensation[6][8]. The combination is used for symptomatic treatment of dry eyes (keratoconjunctivitis sicca), ocular discomfort, minor irritations, or exposure-related dryness. Both components are considered inert with minimal systemic absorption when applied topically. The mechanism involves physical protection and moisture retention on the ocular surface rather than pharmacological receptor targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydroxypropylcellulose + dextran.